Post written by: BioTech Health X
You May Also Like
Oracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding
- BioTech Health X
- August 29, 2021
- 3 minute read
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
Rapid Dose Therapeutics Announces Formation & Appointment of Advisory Board
- BioTech Health X
- July 22, 2021
- 3 minute read
Table of Contents Hide Ron BrooksNick DiRenzoAnne LachanceRapid Dose CEO Mark Upsdell Comment Rapid Dose Therapeutics (CSE:DOSE) is…
Cigna Humana Merger Plans Come To Halt
- BioTech Health X
- December 11, 2023
- 2 minute read
Table of Contents Hide Cigna’s Strategic Response and Market ImpactThe Medicare Advantage FactorFinancial Repercussions of Cigna Humana Merger…
RAPT Therapeutics Announces Promising Phase 2 Trial Results for Tivumecirnon
- BioTech Health X
- April 10, 2024
- 2 minute read
Table of Contents Hide About RAPT TherapeuticsTivumecirnon and Its MechanismClinical Trial InsightsMarket PotentialLooking Forward RAPT Therapeutics, a clinical-stage…
Altasciences Appoints Bruce Frank as Vice President, CDMO Operations
- BioTech Health X
- August 13, 2021
- 2 minute read
Altasciences introduced the appointment of Dr. Bruce Frank, PhD, as Vice President, CDMO Operations. Bruce has thirty years…
BIOQUAL Reports Positive Q3 Growth Following Year of Steady Performance
- BioTech Health X
- April 22, 2024
- 3 minute read
BIOQUAL (OTC Pink: BIOQ) is a company noted for its contributions to health science research. The company’s most…